Loading...
NRO logo

Neurones S.A.ENXTPA:NRO Stock Report

Market Cap €965.7m
Share Price
€39.70
My Fair Value
€52
23.7% undervalued intrinsic discount
1Y-5.4%
7D0.1%
Portfolio Value
​
View

Neurones S.A.

ENXTPA:NRO Stock Report

Market Cap: €965.7m

Neurones (NRO) Stock Overview

An information technology (IT) services company, provides infrastructure, application, and consulting services in France and internationally. More details

NRO fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance3/6
Financial Health5/6
Dividends5/6

Rewards

Trading at 17.4% below our estimate of its fair value

Earnings are forecast to grow 10.87% per year

Earnings grew by 4.7% over the past year

Pays a reliable dividend of 3.27%

Risk Analysis

No risks detected for NRO from our risk checks.

NRO Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Neurones S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Neurones
Historical stock prices
Current Share Price€39.70
52 Week High€52.00
52 Week Low€39.40
Beta0.53
1 Month Change-3.29%
3 Month Change-14.44%
1 Year Change-5.36%
3 Year Change11.05%
5 Year Change61.38%
Change since IPO358.96%

Recent News & Updates

Returns At Neurones (EPA:NRO) Appear To Be Weighed Down

Aug 30
Returns At Neurones (EPA:NRO) Appear To Be Weighed Down

Neurones (EPA:NRO) Has A Rock Solid Balance Sheet

Jun 24
Neurones (EPA:NRO) Has A Rock Solid Balance Sheet

Neurones S.A.'s (EPA:NRO) CEO Looks Due For A Compensation Raise

May 30
Neurones S.A.'s (EPA:NRO) CEO Looks Due For A Compensation Raise

Recent updates

Returns At Neurones (EPA:NRO) Appear To Be Weighed Down

Aug 30
Returns At Neurones (EPA:NRO) Appear To Be Weighed Down

Neurones (EPA:NRO) Has A Rock Solid Balance Sheet

Jun 24
Neurones (EPA:NRO) Has A Rock Solid Balance Sheet

Neurones S.A.'s (EPA:NRO) CEO Looks Due For A Compensation Raise

May 30
Neurones S.A.'s (EPA:NRO) CEO Looks Due For A Compensation Raise

Neurones S.A.'s (EPA:NRO) Shares May Have Run Too Fast Too Soon

Apr 04
Neurones S.A.'s (EPA:NRO) Shares May Have Run Too Fast Too Soon

What Neurones S.A.'s (EPA:NRO) P/E Is Not Telling You

Jul 27
What Neurones S.A.'s (EPA:NRO) P/E Is Not Telling You

Returns On Capital At Neurones (EPA:NRO) Have Hit The Brakes

Apr 26
Returns On Capital At Neurones (EPA:NRO) Have Hit The Brakes

Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement

Dec 01
Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement

If EPS Growth Is Important To You, Neurones (EPA:NRO) Presents An Opportunity

May 18
If EPS Growth Is Important To You, Neurones (EPA:NRO) Presents An Opportunity

Neurones' (EPA:NRO) Returns Have Hit A Wall

Feb 10
Neurones' (EPA:NRO) Returns Have Hit A Wall

Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement

Oct 26
Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement

Does Neurones (EPA:NRO) Deserve A Spot On Your Watchlist?

Sep 22
Does Neurones (EPA:NRO) Deserve A Spot On Your Watchlist?

Neurones (EPA:NRO) Will Pay A Smaller Dividend Than Last Year

Apr 28
Neurones (EPA:NRO) Will Pay A Smaller Dividend Than Last Year

Should You Be Adding Neurones (EPA:NRO) To Your Watchlist Today?

Jan 25
Should You Be Adding Neurones (EPA:NRO) To Your Watchlist Today?

Returns At Neurones (EPA:NRO) Appear To Be Weighed Down

Jan 06
Returns At Neurones (EPA:NRO) Appear To Be Weighed Down

Returns On Capital At Neurones (EPA:NRO) Paint A Concerning Picture

Jul 20
Returns On Capital At Neurones (EPA:NRO) Paint A Concerning Picture

Is Neurones S.A. (EPA:NRO) Trading At A 25% Discount?

May 06
Is Neurones S.A. (EPA:NRO) Trading At A 25% Discount?

Some Investors May Be Worried About Neurones' (EPA:NRO) Returns On Capital

Mar 24
Some Investors May Be Worried About Neurones' (EPA:NRO) Returns On Capital

Neurones S.A.'s (EPA:NRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Mar 09
Neurones S.A.'s (EPA:NRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

The Neurones (EPA:NRO) Share Price Has Gained 54% And Shareholders Are Hoping For More

Feb 16
The Neurones (EPA:NRO) Share Price Has Gained 54% And Shareholders Are Hoping For More

Here's Why Neurones's (EPA:NRO) Statutory Earnings Are Arguably Too Conservative

Jan 25
Here's Why Neurones's (EPA:NRO) Statutory Earnings Are Arguably Too Conservative

What Percentage Of Neurones S.A. (EPA:NRO) Shares Do Insiders Own?

Jan 11
What Percentage Of Neurones S.A. (EPA:NRO) Shares Do Insiders Own?

Should Neurones S.A. (EPA:NRO) Be Part Of Your Dividend Portfolio?

Dec 28
Should Neurones S.A. (EPA:NRO) Be Part Of Your Dividend Portfolio?

Are Neurones S.A. (EPA:NRO) Investors Paying Above The Intrinsic Value?

Dec 15
Are Neurones S.A. (EPA:NRO) Investors Paying Above The Intrinsic Value?

What We Learned About Neurones' (EPA:NRO) CEO Pay

Dec 02
What We Learned About Neurones' (EPA:NRO) CEO Pay

Investors Who Bought Neurones (EPA:NRO) Shares Five Years Ago Are Now Up 39%

Nov 17
Investors Who Bought Neurones (EPA:NRO) Shares Five Years Ago Are Now Up 39%

Neurones (EPA:NRO) Is Growing Earnings But Are They A Good Guide?

Jun 30
Neurones (EPA:NRO) Is Growing Earnings But Are They A Good Guide?

Shareholder Returns

NROFR ITFR Market
7D0.1%0.1%1.6%
1Y-5.4%-30.9%4.1%

Return vs Industry: NRO exceeded the French IT industry which returned -31.6% over the past year.

Return vs Market: NRO underperformed the French Market which returned 4.5% over the past year.

Price Volatility

Is NRO's price volatile compared to industry and market?
NRO volatility
NRO Average Weekly Movement3.6%
IT Industry Average Movement3.9%
Market Average Movement4.6%
10% most volatile stocks in FR Market10.2%
10% least volatile stocks in FR Market2.2%

Stable Share Price: NRO has not had significant price volatility in the past 3 months compared to the French market.

Volatility Over Time: NRO's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19847,087Luc de Chammardwww.neurones.net

Neurones S.A., an information technology (IT) services company, provides infrastructure, application, and consulting services in France and internationally. Its infrastructure services include infrastructure management, manages public and private cloud services, user support, DevOps, cybersecurity, IT service management, information system governance, and automation. The company also provides application services in the areas of Digital, UX/UI, Agile, DevOps, mobility, Data, SAP integration and outsourcing, ECM, EDM, BPM, RPA and paperless processes, IT consulting for the finance, big data, AI and blockchain, IT training, and change management.

Neurones S.A. Fundamentals Summary

How do Neurones's earnings and revenue compare to its market cap?
NRO fundamental statistics
Market cap€965.65m
Earnings (TTM)€50.76m
Revenue (TTM)€832.25m
19.0x
P/E Ratio
1.2x
P/S Ratio

Is NRO overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NRO income statement (TTM)
Revenue€832.25m
Cost of Revenue€421.59m
Gross Profit€410.66m
Other Expenses€359.90m
Earnings€50.76m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)2.09
Gross Margin49.34%
Net Profit Margin6.10%
Debt/Equity Ratio9.6%

How did NRO perform over the long term?

See historical performance and comparison

Dividends

3.3%
Current Dividend Yield
60%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/09/12 12:57
End of Day Share Price 2025/09/12 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Neurones S.A. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gilbert FerrandArkeon Finance
Alexandre PlaudCIC Market Solutions (ESN)
Richard-Maxime BeaudouxNatixis S.A.